Claret Asset Management Corp Exelixis, Inc. Transaction History
Claret Asset Management Corp
- $633 Million
- Q4 2024
A detailed history of Claret Asset Management Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 9,012 shares of EXEL stock, worth $315,420. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,012
Previous 8,949
0.7%
Holding current value
$315,420
Previous $232,000
29.31%
% of portfolio
0.05%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
562Shares Held
251MCall Options Held
1.5MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$820 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$535 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$399 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...